Clearstead Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Buy |
1,683
+490
| +41% | +$61.5K | ﹤0.01% | 876 |
|
|
2025
Q1 | $163K | Buy |
1,193
+75
| +7% | +$10.3K | ﹤0.01% | 878 |
|
|
2024
Q4 | $171K | Sell |
1,118
-302
| -21% | -$46.2K | ﹤0.01% | 900 |
|
|
2024
Q3 | $275K | Sell |
1,420
-37
| -3% | -$7.17K | ﹤0.01% | 750 |
|
|
2024
Q2 | $338K | Buy |
1,457
+16
| +1% | +$3.71K | 0.01% | 635 |
|
|
2024
Q1 | $325K | Sell |
1,441
-387
| -21% | -$87.2K | 0.02% | 388 |
|
|
2023
Q4 | $473K | Sell |
1,828
-1,525
| -45% | -$395K | 0.03% | 315 |
|
|
2023
Q3 | $862K | Buy |
3,353
+1,905
| +132% | +$490K | 0.03% | 324 |
|
|
2023
Q2 | $412K | Sell |
1,448
-3
| -0.2% | -$855 | 0.03% | 316 |
|
|
2023
Q1 | $403K | Sell |
1,451
-2
| -0.1% | -$556 | 0.03% | 291 |
|
|
2022
Q4 | $402K | Hold |
1,453
| – | – | 0.03% | 282 |
|
|
2022
Q3 | $388K | Hold |
1,453
| – | – | 0.04% | 268 |
|
|
2022
Q2 | $296K | Hold |
1,453
| – | – | 0.02% | 320 |
|
|
2022
Q1 | $306K | Buy |
1,453
+226
| +18% | +$47.6K | 0.02% | 343 |
|
|
2021
Q4 | $294K | Buy |
1,227
+213
| +21% | +$51K | 0.02% | 328 |
|
|
2021
Q3 | $287K | Hold |
1,014
| – | – | 0.02% | 318 |
|
|
2021
Q2 | $351K | Buy |
1,014
+492
| +94% | +$170K | 0.03% | 267 |
|
|
2021
Q1 | $146K | Buy |
522
+138
| +36% | +$38.6K | 0.01% | 370 |
|
|
2020
Q4 | $94K | Hold |
384
| – | – | 0.01% | 424 |
|
|
2020
Q3 | $109K | Buy |
384
+114
| +42% | +$32.4K | 0.01% | 360 |
|
|
2020
Q2 | $72K | Hold |
270
| – | – | 0.01% | 391 |
|
|
2020
Q1 | $85K | Buy |
+270
| New | +$85K | 0.01% | 345 |
|